ABSTRACT
INTRODUCTION
The hemangiopericytoma is a rare and potentially malignant vascular tumor, which includes 1% of vascular tumors (1) . It originates from the mesenchymal cells of the pericyte (1, 2) . We report a case of interest because of its rarity, size and location.
CASE REPORT
This is a 63-year-old woman who consulted for abdominal pain. The CT and MRI showed a solid cystic mass of 12 x 9 x 9.4 cm with punctate calcifications and a rich vascularity occupying almost the entire Douglas space, displacing the uterus (U), bladder (V) and the right side of sigmoid colon, but without infiltrating them. The study was completed with an arteriography that showed vascular contributions relative to the inferior mesenteric artery (IMA) and both hypogastric arteries (AH) (Fig. 1) . Fig. 1 . The MRI showed a big pelvic tumor displacing the uterus (U), bladder (V) and sigmoid colon. The arteriography showed vascular contributions relative to the inferior mesenteric artery (IMA) and both hypogastric arteries (AH).
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Prior to the surgery, a selective embolization of the tumor vasculature was performed to reduce the risk of intraoperative bleeding, and then, the pelvic mass was successfully removed without intra-or postoperative complications. Histology confirmed the diagnosis of pelvic hemangiopericytoma with free resection edges. The patient is currently being monitored as an outpatient with no clinical or radiological signs of recurrence to date.
DISCUSSION
Hemangiopericytoma is a rare tumor of the pericyte that surrounds capillaries and venules, so it can occur at any location (1,3) . The most common locations are the lower limbs, followed by the retroperitoneal area. Pelvic location is exceptional.
Clinically, the tumor usually appears as a painless mass, but it may also show signs of compression of neighboring organs or the development of paraneoplastic syndromes (1,2,4,5). CT and angiography confirm the diagnosis. Percutaneous biopsy is not recommended because of the high risk of bleeding. The definitive diagnosis is anatomopathological after analyzing the surgical specimen (6) . The distinction between benign or malignant hemangiopericitoma is based on clinical and pathological criteria (7) . It is considered to be malignant if it invades nearby structures, develops metastasis or recurs during follow-up (7). Although there is no histological pattern of malignancy, it has been shown that size, high mitotic index, high cellularity and the presence of necrosis or hemorrhage can promote the development of recurrence and/or metastasis (2,7). The treatment of choice is complete resection, sometimes preceded by embolization of the vascularization of the mass to decrease the risk of bleeding (1, 7, 8) . There is disagreement about the effectiveness of chemo/radiotherapy as the primary treatment. The use of adjuvant radiation therapy has been described for improving local control and reducing recurrences, although it is considered to be a relatively radio-resistant tumor (1,2,9,10). The prognosis is conditional on achieving a complete resection, with five-and ten-year survival rates between 70 and 80%, depending on the series (6) . The recurrence rate ranges between 20 and 50% after resection. Long-term monitoring is recommended because recurrence may appear at a later time (2) .
